Homepage
Medication Guide
Indications of Elafibranor
Elafibranor is a peroxisome proliferator-activated receptor (PPAR) agonist, which was first approved for marketing in the United States in 2024. As an innovative drug, it provides a new treatment opti...
508
Monday, September 15th, 2025, 16:43
What Are the Side Effects of Vibegron Tablets?
Vibegron is an important therapeutic drug whose efficacy has been verified through clinical trials. However, patients still need to be aware of its potential side effects and medication precautions.Wh...
504
Monday, September 15th, 2025, 16:19
What Are the Side Effects of Glasdegib Film-Coated Tablets?
Glasdegib Film-Coated Tablets are a type of Smoothened (SMO) inhibitor. In 2018, they were approved by the U.S. FDA for combination use with low-dose cytarabine in the treatment of newly diagnosed acu...
503
Monday, September 15th, 2025, 16:14
How Effective is Glasdegib Film-Coated Tablets in Treatment?
Glasdegib Film-Coated Tablets are an innovative Hedgehog signaling pathway inhibitor, first approved in the United States in 2018. As a targeted therapy drug, it provides a new treatment option for pa...
506
Monday, September 15th, 2025, 16:11
How to Use Glasdegib Film-Coated Tablets
Glasdegib film-coated tablets are a type of Smoothened (SMO) inhibitor. Approved in the United States in 2018, they are indicated for the treatment of newly diagnosed acute myeloid leukemia (AML) in c...
507
Monday, September 15th, 2025, 15:36
How Effective is Elafibranor in Treatment?
Elafibranor is a peroxisome proliferator-activated receptor (PPAR) agonist, providing a new treatment option for patients with an inadequate response to or intolerance of ursodeoxycholic acid (UDCA).H...
510
Monday, September 15th, 2025, 15:30
Precautions for Administration of Elafibranor (Elafibranor)
Elafibranor is a peroxisome proliferator-activated receptor (PPAR) agonist that improves liver function parameters by activating PPAR receptors.Precautions for Administration of Elafibranor (Elafibran...
508
Monday, September 15th, 2025, 15:21
How to Use Elafibranor
Elafibranor is a peroxisome proliferator-activated receptor (PPAR) agonist. Approved in the United States in 2024 for the treatment of primary biliary cholangitis (PBC), it is indicated for use in com...
505
Monday, September 15th, 2025, 15:12
How Effective is Vibegron in Treatment?
Vibegron is a selective β-3 adrenergic receptor agonist that was first approved for marketing in the United States in 2020. As an innovative drug for the treatment of overactive bladder (OAB), it prov...
505
Monday, September 15th, 2025, 14:56
Precautions for Vibegron Administration
Vibegron is a selective β3-adrenergic receptor agonist. It was first approved in the United States in 2020 for the treatment of overactive bladder (OAB) in adults. As a novel drug for OAB treatment, V...
503
Monday, September 15th, 2025, 14:51
117 / 207
2069 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved